UK charity donates generous funding for eye disease treatment

Article

Fight for Sight has donated £1.6 million towards ten research grants focused on tackling sight loss and eye disease treatment.

Fight for Sight has donated £1.6 million towards ten research grants focused on tackling sight loss and eye disease treatment.

The research grants will be given to a clinical fellowship, two early career investigator awards and seven project grants. Work will begin universities and hospitals across the UK and aims to develop treatment for age-related macular degeneration, glaucoma, eyelid cancer, inherited paediatric retinal disease and diabetic retinopathy.

Dr Dolores Conroy, Director of Research at Fight for Sight, commented, "Currently, there are a huge number of eye conditions that we do not know enough about, and which have few treatment options – such as age-related macular degeneration and diabetic retinopathy. It is therefore crucial that we invest as much as we can into research, which could bring us closer to finding new ways to help people living with sight loss. We hope our commitment to funding pioneering research will bring us even closer to a future everyone can see.”

To find out more about the charity please click here

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.